Cargando…
Fibrinolytic and antithrombotic therapy : theory, practice, and management /
Thrombotic disorders of the circulatory system represent the leading cause of morbidity, mortality, and health care expenditure in the United States. The Second Edition of Fibrinolytic and Antithrombotic Therapy provides a practical, evidence-based approach to the managment of thrombotic disorders f...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Oxford ; New York :
Oxford University Press,
2006.
|
| Edición: | 2nd ed. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a22000004a 4500 | ||
|---|---|---|---|
| 001 | EBSCO_ocm71794280 | ||
| 003 | OCoLC | ||
| 005 | 20231017213018.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 060928s2006 enka ob 001 0 eng d | ||
| 010 | |a 2005012980 | ||
| 040 | |a N$T |b eng |e pn |c N$T |d YDXCP |d OCLCG |d OCLCQ |d N$T |d OCLCQ |d E7B |d CBT |d OCLCQ |d NLGGC |d OCLCO |d OCLCQ |d EBLCP |d OCLCQ |d AZK |d TOA |d AGLDB |d MOR |d OCLCO |d PIFAG |d ZCU |d OCLCO |d MERUC |d OCLCO |d OCLCQ |d OCLCO |d WY@ |d OCLCO |d OCLCA |d U3W |d OCLCO |d OCLCA |d LUE |d OCLCO |d OCLCF |d OCLCO |d STF |d WRM |d OCLCQ |d VTS |d CEF |d ICG |d NRAMU |d VT2 |d AU@ |d OCLCO |d OCLCQ |d LHU |d OCLCO |d FVL |d OCLCQ |d WYU |d UWO |d OCLCO |d OCLCA |d CANPU |d OCLCO |d REC |d OCLCO |d DKC |d OCLCQ |d CNTRU |d OCLCO |d MT4IT |d UX1 |d OCLCA |d UKCRE |d UKAHL |d OCLCO |d SGP |d OCLCO |d OCLCQ |d SFB |d OCLCQ | ||
| 015 | |a GBA616392 |2 bnb | ||
| 015 | |a GBA616392. |2 bnb | ||
| 016 | 7 | |z 101247345 |2 DNLM | |
| 016 | 7 | |z 013385935 |2 Uk | |
| 016 | 7 | |z 013385935. |2 Uk | |
| 016 | 7 | |z 101247345. |2 DNLM | |
| 019 | |a 647897721 |a 764534359 |a 961485118 |a 962646807 |a 988492310 |a 991913422 |a 992050685 |a 1035697255 |a 1037927771 |a 1038668593 |a 1045522518 |a 1059790148 |a 1064644548 |a 1081256274 |a 1099557953 |a 1153504722 | ||
| 020 | |a 9780199749065 |q (electronic bk.) | ||
| 020 | |a 019974906X |q (electronic bk.) | ||
| 020 | |a 1429402733 | ||
| 020 | |a 9781429402736 | ||
| 020 | |z 9780195155648 |q (alk. paper) | ||
| 020 | |z 0195155645 |q (alk. paper) | ||
| 027 | |a MYILIB_CUp | ||
| 029 | 1 | |a AU@ |b 000044593692 | |
| 029 | 1 | |a AU@ |b 000051581888 | |
| 029 | 1 | |a AU@ |b 000062338105 | |
| 029 | 1 | |a DEBBG |b BV043118871 | |
| 029 | 1 | |a DEBBG |b BV044094264 | |
| 029 | 1 | |a DEBSZ |b 422253847 | |
| 029 | 1 | |a NZ1 |b 13863936 | |
| 029 | 1 | |a YDXCP |b 2472905 | |
| 029 | 1 | |a AU@ |b 000069138377 | |
| 029 | 1 | |a DKDLA |b 820120-katalog:999941375805765 | |
| 029 | 1 | |a AU@ |b 000060545862 | |
| 035 | |a (OCoLC)71794280 |z (OCoLC)647897721 |z (OCoLC)764534359 |z (OCoLC)961485118 |z (OCoLC)962646807 |z (OCoLC)988492310 |z (OCoLC)991913422 |z (OCoLC)992050685 |z (OCoLC)1035697255 |z (OCoLC)1037927771 |z (OCoLC)1038668593 |z (OCoLC)1045522518 |z (OCoLC)1059790148 |z (OCoLC)1064644548 |z (OCoLC)1081256274 |z (OCoLC)1099557953 |z (OCoLC)1153504722 | ||
| 050 | 4 | |a RC694.3 |b .B39 2006eb | |
| 055 | 1 | 3 | |a RC694.3 |b .B39 2006eb |
| 060 | 0 | 0 | |a 2006 F-938 |
| 060 | 1 | 0 | |a QZ 170 |b B396f 2006 |
| 072 | 7 | |a MED |x 010000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.1/3506 |2 22 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Becker, Richard C. | |
| 245 | 1 | 0 | |a Fibrinolytic and antithrombotic therapy : |b theory, practice, and management / |c Richard C. Becker, Frederick A. Spencer. |
| 250 | |a 2nd ed. | ||
| 260 | |a Oxford ; |a New York : |b Oxford University Press, |c 2006. | ||
| 300 | |a 1 online resource (x, 410 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Historical perspectives in hemostasis, coagulation and fibrinolysis -- Vascular biology, thromboresistance and inflammation -- Atherosclerosis and arterial thrombosis -- Venous thromboembolism -- Cardiac chamber, aortic and valvular thromboembolism -- Fibrinolytic agents -- Aspirin -- Clopidogrel -- Platelet Glycoprotein IIb/IIIa receptor antagonists -- Aggrenox and cilostazol -- Novel platelet antagonists. | |
| 505 | 0 | |a Combination pharmacotherapy -- Facilitated percutaneous coronary intervention -- Thrombin-directed therapy -- Factor Xa inhibitors -- Direct thrombin inhibitors -- Novel anticoagulants -- Acute coronary syndromes -- Peripheral vascular disease and stroke -- Valvular heart disease and atrial fibrillation -- Plaque-stabilizing therapies. | |
| 505 | 0 | |a Venous thromboembolism prophylaxis -- Venous thromboembolism treatment -- Fundamentals and patient evaluation -- Platelet antagonists -- Anticoagulants -- Anticoagulation clinics and self-testing -- Platelet antagonists -- Anticoagulants -- Fibrinolytic agents. | |
| 588 | 0 | |a Print version record. | |
| 520 | 8 | |a Thrombotic disorders of the circulatory system represent the leading cause of morbidity, mortality, and health care expenditure in the United States. The Second Edition of Fibrinolytic and Antithrombotic Therapy provides a practical, evidence-based approach to the managment of thrombotic disorders for all clinicians involved in the care of patients with these disorders. It provides not only vital conceptual information on fibrinolytic and antithrombotic therapy, but also the means to apply it to everyday decision making and patient care. Focusing on management guidelines and critical pathways, the text stresses practicality and usability. It will be a valuable resource for the wide range of clinicians involved in the care of patients with these disorders. | |
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 650 | 0 | |a Thrombolytic therapy. | |
| 650 | 0 | |a Fibrinolytic agents. | |
| 650 | 0 | |a Thrombosis |x Treatment. | |
| 650 | 1 | 2 | |a Thrombolytic Therapy |x methods |
| 650 | 2 | 2 | |a Blood Coagulation Disorders |x drug therapy |
| 650 | 2 | 2 | |a Blood Coagulation Disorders |x physiopathology |
| 650 | 2 | 2 | |a Cardiovascular Diseases |x drug therapy |
| 650 | 2 | 2 | |a Fibrinolytic Agents |x therapeutic use |
| 650 | 2 | |a Thrombolytic Therapy | |
| 650 | 2 | |a Fibrinolytic Agents | |
| 650 | 6 | |a Thrombolyse. | |
| 650 | 6 | |a Fibrinolytiques. | |
| 650 | 6 | |a Thrombose |x Traitement. | |
| 650 | 7 | |a MEDICAL |x Cardiology. |2 bisacsh | |
| 650 | 7 | |a Fibrinolytic agents. |2 fast |0 (OCoLC)fst00923665 | |
| 650 | 7 | |a Thrombolytic therapy. |2 fast |0 (OCoLC)fst01150419 | |
| 700 | 1 | |a Spencer, Fredrick A., |c MD. | |
| 776 | 0 | 8 | |i Print version: |a Becker, Richard C. |t Fibrinolytic and antithrombotic therapy. |b 2nd ed. |d Oxford ; New York : Oxford University Press, 2006 |z 0195155645 |w (DLC) 2005012980 |w (OCoLC)60348893 |
| 856 | 4 | 0 | |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=168946 |z Texto completo |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH38694139 | ||
| 938 | |a EBL - Ebook Library |b EBLB |n EBL3053633 | ||
| 938 | |a ebrary |b EBRY |n ebr10375127 | ||
| 938 | |a EBSCOhost |b EBSC |n 168946 | ||
| 938 | |a YBP Library Services |b YANK |n 3248552 | ||
| 938 | |a YBP Library Services |b YANK |n 2472905 | ||
| 994 | |a 92 |b IZTAP | ||